0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BridgeBio Pharma Inc - Trending symbols

Latest News of BridgeBio Pharma Inc

DateTitleRead
2025-06-17
12:40
BridgeBio stock initiated with outperform rating by Wolfe ResearchRead
2025-06-14
22:59
Alnylam Pharmaceuticals' SWOT analysis: stock poised for growth in expanding ATTR-CM marketRead
2025-06-14
15:37
BridgeBio Pharma's SWOT analysis: stock poised for growth amid challengesRead
2025-05-23
21:21
Rocket Cos., Middleby, Diebold Nixdorf, and More Stocks See Action From Activist InvestorsRead
2025-05-20
13:30
Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CMRead
2025-05-19
18:33
Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM StudyRead

Notifications

TypeNotificationDate
RSI OverboughtOverbought RSI (Relative Strength Index)2025-06-17



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Debt 1,253,42067,9031,321,323142,1021,463,425-413,9421,049,483-1,579,958-530,475
Accumulated Other Comprehensive Income 63-2934-331-292-6-4
EBIT -126,163-10,415-136,578-22,753-159,331-11,483-170,814174,5573,743
EBITDA -117,609-17,332-134,941-22,751-157,692-11,537-169,229174,5685,339
Operating Income -126,163-19,936-146,099-11,593-157,692-19,724-177,416181,1593,743
Total Other Income Expense Net -18,3821,813-16,56914,514-2,055-17,252-19,30740,33121,024
Income Tax Expense 8,2237,18015,40318,71134,114-14,84819,266-20,905-1,639
Other Current Liabilities 113,309-24,31688,99331,874120,867-23,39397,474-109,305-11,831
Gross Profit 89010,44511,335-10,98934672,70073,046-73,447-401
Minority Interest 5,9298756,804-2,2484,556-1,1443,412-3,439-27

Comments

How you think about this?

Leave a comment

Stay informed about BridgeBio Pharma Inc.

Receive notifications about BridgeBio Pharma Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.